SFTPD and Increased total eosinophil count: The study demonstrated that intranasal treatment with SP-D or rhSP-D (a recombinant fragment of human SP-D containing trimeric C-type lectin domains) significantly lowered eosinophilia and specific antibody levels in mice with Afu-induced pulmonary hypersensitivity.